LC51-0255

DRUG2 trials

Sponsors

LG Chem

Conditions

HealthyUlcerative Colitis

Phase 1

A Study To Evaluate The Safety, Pharmacokinetics/Pharmacodynamics (PK/PD) and Food Effect Of LC51-0255

CompletedNCT03174613

Start: 2017-05-31End: 2019-07-11Updated: 2020-09-18

Phase 2

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

WithdrawnNCT04096573

LG ChemUlcerative Colitis

Start: 2020-04-30End: 2022-08-31Updated: 2021-11-15